|
BristamycinDrug - Bristamycin The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Erythromycin Stearate
Strength -
EQ 250MG BASE
Applicant -
BRISTOL
New Drug Application (NDA) Number -
061304
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Laboratories Inc Div Bristol Myers Co
Bristamycin
Erythromycin Eq 1gm Base/vial Injectable; Injection
Erythromycin Eq 500mg Base/vial Injectable; Injection Erythromycin Lactobionate Eq 1gm Base/vial Injectable; Injection Erythromycin Lactobionate Eq 500mg Base/vial Injectable; Injection Erythromycin Lactobionate Eq 1gm Base/vial Injectable; Injection Erythromycin Lactobionate Eq 500mg Base/vial Injectable; Injection Erythromycin Lactobionate Eq 1gm Base/vial Injectable; Injection Erythromycin Lactobionate Eq 500mg Base/vial Injectable; Injection Bristamycin Eq 250mg Base Tablet; Oral Erythrocin Eq 500mg Base/vial Injectable; Injection NewDrugInformation |